|
|
Life Sciences Technology
|
|
Devices, Diagnostics, & Distribution
|
|
New medical technologies and breakthroughs have led to the use of gene-based diagnostics in the detection of diseases. These new diagnostics, driven by genomics and imaging technologies, are leading to a new area of interest, Theranostics. These new tools and therapies will have an impact on the evolving demographics.
Devices that utilize biotechnology are having an impact on the use of more traditional cardiology procedures. New interventional technologies and procedures in particular in the areas of minimally invasive surgery may reduce the use of some traditional techniques. The convergence of medical devices and pharmaceuticals will challenge traditional protocols and create new marketing opportunities along with challenging operations and regulatory issues. New product developments and/or acquisition will speed the development and implementation of these new technologies.
Practice Leader:
John Baker - Boston
Consultants:
Carl Bretko - Philadelphia
Michael Carey - New York
Kim Chan - Singapore
Eric Dieny - Shanghai
Supriya Dikshit - Mumbai
Caroline Edwards - Hong Kong**
Victor Filamor - Hong Kong**
John R. Hamilton - Pittsburgh
Julie Kanak - Chicago***
Sussannah Kelly - Toronto
Dhanee Kieosangsong - Bangkok
Victor Kleinman - Palm Beach
Kelvin Ling - Hong Kong**
Carolyn Lowe - Philadelphia
James McFadzean - Silicon Valley
John McLean - Chicago***
Larry Munson - St. Louis
Mike Nagata - Tokyo
Mercedes Paz - Los Angeles
Bart Penfold - San Francisco
Scott Rabinowitz - Seattle
William Ross - Los Angeles
Shigemasa Saida - Tokyo
Johannes Suciu - Frankfurt
Dennis Taylor - St. Louis
Sherry Wang - Taipei
Jan Westerink - Amsterdam**
Lauren Lee White - Newark
Lance Winn - Austin
Dan Xie - Shanghai
Frederik van der Zeeuw - Amsterdam**
|
|